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Cyclooxygenase-2 (COX-2) is believed to be a multifunctional neural modulator that affects synaptic
plasticity in the hippocampus. In the present study, we investigated the differential effects of treadmill
exercise on COX-2 immunoreactivity in the dentate gyrus in early and chronic diabetic stages in Zucker
diabetic fatty (ZDF) rats and lean control (ZLC) rats. To this end, ZLC and ZDF rats at 6 or 23 weeks of
age were put on a treadmill with or without running for 1 h/day for 5 consecutive days at 16-22 m/min
for 5 weeks or 12-16 m/min for 7 weeks, respectively. Treadmill exercise in prediabetic and chronic
diabetic rats significantly reduced blood glucose levels. In particular, exercise in the prediabetic rat
blocked the onset of diabetes. COX-2 immunoreactivity was mainly detected in the granule cell layer of
the dentate gyrus and stratum pyramidale of the CA3 region in all groups. COX-2 immunoreactivity was
significantly increased in these regions of ZLC and ZDF rats after treadmill exercise in the early diabetic
stage. However, COX-2 immunoreactivity was not changed in these regions in ZDF rats after treadmill
exercise in the chronic stage. These results suggest that treadmill exercise in diabetic animals in the
chronic stage has limited ability to cause plasticity in the dentate gyrus.
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Cyclooxygenase (COX), also known as prostaglandin (PG)
H synthase, is a rate-limiting enzyme in the production of
PG from two isozymes, constitutive COX-1 and inducible
COX-2 [1]. COX-2, which is expressed in response to
inflammatory stimuli in peripheral tissue [2], plays an essential
role in neuroinflammation. COX-2 is also expressed at high
levels in discrete populations of neurons within cortical and
limbic regions, such as the hippocampus and amygdala [1,3,4].
In this regard, COX-2 is an inflammatory mediator [2], as
well as a multifunctional neural modulator that affects synaptic
plasticity [5,6].
Diabetes may directly affect the brain because brain insulin
receptors, as well as insulin-sensitive glucose transporters, are
regionally distributed throughout the central nervous system
with differential levels of expression in brain regions subserving
affective and cognitive functions [7]. We previously reported
that diabetes significantly decreases cellular proliferation and
neuroblast differentiation in the dentate gyrus of type-2 diabetic
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rats [8,9]. Among diabetic animal models, Zucker diabetic
fatty (ZDF) rats are characterized by a mutation in the leptin
receptor, which results in high levels of circulating leptin,
glucose, insulin, and lipids. Diabetic phenotypes in this animal,
which appear between 7 and 10 weeks of age, are maintained
for at least 6 months [10,11].
Physical exercise is associated with decreases in the risk
of cognitive impairment, improvements in learning and
memory capability, and improvements in the recovery of brain
functions after brain damage [12-15]. Nuclear factor-kappa
B (NF-κB) activity was profoundly reduced after chronic
exercise in an exercise intensity-dependent manner in
Alzheimer’s disease mice [16]. Our previous study showed
that the effects of exercise on glucose levels in the blood
and on cellular proliferation and neuroblast differentiation
in the dentate gyrus were different in the early and chronic
stages of diabetes [9]. However, there are no comparative
studies on the effects of exercise on COX-2 immunoreactivity
in rats in the early and chronic stages of diabetes. In the
present study, therefore, we investigated changes in COX-
2 immunoreactivity in the hippocampus of ZDF rats and
lean control (ZLC) rats.
Materials and Methods
Experimental animals
Male and female heterozygote type (Lepr
fa/+) ZDF rats were
purchased from Genetic Models (Indianapolis, ME, USA) and
mated. They were housed in a conventional state under
adequate temperature (23
oC) and humidity (60%) control
with a 12-h light/12-h dark cycle, and free accesses to food
and water. Purina 5008 rodent diet (7.5% fat) was provided
as recommended by Genetic Models Co. (Purina, St. Louis,
MO, USA). The procedures for the care and handling of
animals conformed to guidelines that are in compliance with
current international policies on the handling and caring of
animals. These guidelines follow the Guide for the Care and
Use of Laboratory Animals issued by the Institute of Laboratory
Animal Resources, USA, 1996, and a protocol for it was
approved by the Institutional Animal Care and Use Committee
(IACUC) of Seoul National University. All of the experiments
were designed to minimize the number of animals used and
the suffering caused by the procedures used in the present
study.
Genotyping of Lepr
fa gene and experimental design
The genotype of Lepr
fa was determined using the strategy
described in our previous study [8]. For effects of exercise
on COX-2 immunoreactivity at early and chronic stages, 20
male ZLC and ZDF rats were randomly divided into 4 groups
(n=5 per group): sedentary and exercise groups. Running
speed and exercise duration was determined according to
Lawler’s protocol to correspond to 75% of maximal oxygen
uptake [17]. At 6 or 23 weeks of age, exercise groups were
familiarized with treadmill running on a motorized treadmill
(Model 1050 LS Exer3/6; Columbus Instruments, Columbus,
OH, USA) for 15 min/day at 15 or 12 m/min for 5 consecutive
days, respectively. After familiarization, electrical stimulation
to encourage the rats to run was disconnected to avoid pain
stress. For early stage diabetes experiments, rats were run
for 1 h/day for 5 consecutive days at 16 m/min for 5 weeks
and the speeds accelerated 2 m/min per day over 2 weeks.
For chronic stage diabetes experiment, rats were run for 1 h/
day for 5 consecutive days at 12 m/min for 7 weeks; speeds
were accelerated 1 m/min per day over 2 weeks. The control
group was put on the treadmill without running for 1 h/day
for 5 consecutive days for 5 or 7 weeks. All animals were
euthanized at 12 or 30 weeks of age.
Blood glucose levels
Blood (fed glucose, not fast glucose) was sampled by “tail
nick” between 9 and 11 AM using a 27G needle before
sacrifice. Blood was analyzed immediately after anesthesia
using a blood glucose monitor (Ascensia Elite XL Blood Glucose
Meter; Bayer, Toronto, ON, Canada). 
Tissue processing
For histological analysis, animals in each group were
anesthetized with 30 mg/kg tiletamine and zolazepam (Zoletil
50
®; Virbac, Carros, France) and perfused transcardially with
0.1 M phosphate-buffered saline (PBS, pH 7.4) followed by
4% paraformaldehyde in 0.1 M phosphate-buffer (PB, pH
7.4). Brains were removed and postfixed in the same fixative
for 6 hr. The brain tissues were cryoprotected by infiltration
with 30% sucrose overnight. The 30-µm-thick brain sections
in the coronal plane were serially cut using a cryostat (Leica,
Wetzlar, Germany). The sections were collected into six-well
plates containing PBS for further process.
Immunohistochemistry for COX-2
To obtain accurate data for immunohistochemistry, free-
floating sections were carefully processed under the same
conditions. The tissue sections were selected at points from
−3.00~ −4.08 mm to bregma [18]. Sections were sequentially
treated with 0.3% hydrogen peroxide (H2O2) in PBS for 30
min and 10% normal goat serum in 0.05 M PBS for 30
min. They were then incubated with diluted rabbit anti-COX-
2 (1:200, Cayman, Ann Arbor, MI, USA) overnight at roomEffect of diabetes on cyclooxygenase-2 191
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temperature and subsequently exposed to biotinylated goat
anti-rabbit IgG and streptavidin peroxidase complex (1:200,
Vector, Burlingame, CA, USA). They were then visualized
by reaction with 3,3’-diaminobenzidine tetrachloride (Sigma,
St. Louis, MO, USA) in 0.1 M Tris-HCl buffer (pH 7.2) and
mounted on gelatin-coated slides. Sections were mounted
in Canada Balsam (Kanto, Tokyo, Japan) following dehydration. 
Analysis of a region of interest (ROI) in the hippocampus
was performed using an image analysis system. Images were
calibrated in an array of 512×512 pixels corresponding to
a tissue area of 140×140 µm (×40 primary magnification).
Each pixel resolution was 256 gray levels. The intensity of
COX-2 immunoreactivity was evaluated by means of a relative
optical density (ROD), which was obtained after the
transformation of the mean gray level using the formula:
ROD=log (256/mean gray level). The ROD of the background
was determined in unlabeled portions and the value subtracted
for correction, yielding high ROD values in the presence of
preserved structures and low values after structural loss using
NIH Image 1.59 software. A ratio of ROD values was calculated
as a %.
Statistical analysis
The data shown here represent the means of experiments
performed for each experimental area. Differences among
means were statistically analyzed by two-way analysis of
variance followed by Duncan’s post-hoc analysis in order
to elucidate differences between 1) sedentary vs exercise
groups, 2) 12 vs 30 weeks old groups, and 3) ZLC vs ZDF groups.
Results
Change in blood glucose levels
In 12-week-old ZLC and ZDF rats that were sedentary
(Co12-ZLC and Co12-ZDF), blood glucose levels were 5.89
mmol/L and 21.3 mmol/L, respectively. In 12-week-old rats
in that exercised (Ex12-ZLC and Ex12-ZDF), blood glucose
levels were similar to those in the Co12-ZLC group (Figure 1).
In 30-week-old ZLC and ZDF rats that were sedentary
(Co30-ZLC and Co30-ZDF), blood glucose levels were 6.31
mmol/L and 29.9 mmol/L, respectively. In 30-week-old rats
that exercised (Ex30-ZLC and Ex30-ZDF), blood glucose levels
were 6.18 mmol/L and 20.9 mmol/L, respectively (Figure 1).
Change in COX-2 immunoreactivity in the dentate
gyrus
In the Co12-ZLC group, COX-2 immunoreactivity was
detected in the granule cells and in the CA4 region of the
dentate gyrus (Figure 2A). COX-2 immunoreactivity was mainly
observed in the dorsal blade of the dentate gyrus. In the
Co12-ZDF group, a few COX-2-immunoreactive cells were
detected in the granule cell layer and CA4 region (Figure
2B). Overall, COX-2 immunoreactivity was significantly
decreased in the Co12-ZDF group compared to the Co12-
ZLC group (Figure 4A). In the Ex12-ZLC group, COX-2
immunoreactivity was significantly increased in the dentate
gyrus and CA4 region compared to the Co12-ZLC group
(Figures 2C and 4A). In the Ex12-ZLC group, COX-2-
immunoreactive cells were few in the ventral blade of the
dentate gyrus (Figure 2C). In the Ex12-ZDF group, COX-2
immunoreactivity was significantly decreased in the dentate
gyrus and CA4 region compared to the Co12-ZDF group
(Figures 2D and 4A), but COX-2 immunoreactivity was
significantly increased compared to the Co12-ZDF group
(Figure 4A). In this group, COX-2 immunoreactivity was similar
to the Co12-ZLC group (Figure 4A).
In the Co30-ZLC group, COX-2 immunoreactivity in the
dentate gyrus and CA4 region was similar to that in the Co12-
ZLC group (Figures 2E and 4A). In the Co30-ZDF group,
COX-2 immunoreactivity in the dentate gyrus and CA4 region
was significantly decreased compared to that in the Co30-
ZLC group (Figures 2F and 4A). In this group, COX-2
immunoreactivity was similar to that in the Co12-ZDF group
(Figure 4A). In the Ex30-ZLC group, COX-2 immunoreactivity
in the dentate gyrus and CA4 region was slightly, but not
significantly, increased compared to that in the Co30-ZLC
group (Figures 2G and 4A). In this group, COX-2
immunoreactivity was significantly decreased compared to
that in the Ex12-ZLC group (Figure 4A). In the Ex30-ZDF
group, COX-2 immunoreactivity was similar to that in the
Figure 1. Change in blood glucose levels in 12-week-old
Zucker lean control (ZLC) and Zucker diabetic fatty (ZDF) rats
in the sedentary groups (Co12-ZLC and Co12-ZDF), in the 12-
week-old rats in the exercised groups (Ex12-ZLC and Ex12-
ZDF), in the 30-week-old rats in the sedentary groups (Co30-
ZLC and Co30-ZDF), and in the 30-week-old rats in the
exercised groups (Ex30-ZLC and Ex30-ZDF rats; n=5 per
group; 
aP<0.05, significantly different from control group;
bP<0.05, significantly different from the ZLC group; 
cP<0.05,
significantly different from 12-week-old age group). The bars
indicate the SEM.192 Sung Min Nam et al.
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Co30-ZLC and Ex30-ZLC group as well as in the Ex12-ZDF
group (Figures 2H and 4A).
Changes  in COX-2  immunoreactivity in  the CA3
region
In the Co12-ZLC group, COX-2 immunoreactivity was
mainly detected in the pyramidal cells of the stratum
pyramidale (Figure 3A). In the Co12-ZDF group, COX-2
immunoreactivity in the hippocampal CA3 region was
significantly decreased compared to that in the Co12-ZLC
group (Figures 3B and 4B). In the Ex12-ZLC group, COX-
2 immunoreactivity was significantly increased compared to
that in the Co12-ZLC group (Figures 3C and 4B). In the
Ex12-ZDF group, COX-2 immunoreactivity in the hippocampal
CA3 region was significantly decreased compared to that in
the Ex12-ZLC group, but COX-2 immunoreactivity was
significantly increased compared to that in the Co12-ZDF
group (Figures 3D and 4B).
In the Co30-ZLC group, COX-2 immunoreactivity in the
hippocampal CA3 region was similar to that in the Co12-
ZLC group (Figures 3E and 4B). In the Co30-ZDF group,
COX-2 immunoreactivity in the hippocampal CA3 region was
significantly decreased compared to that in the Co30-ZLC
group, and it was similar to that in the Co12-ZDF group
(Figures 3F and 4B). In the Ex30-ZLC group, COX-2
immunoreactivity was significantly increased compared to that
in the Co30-ZLC group and decreased compared to that
in the Ex12-ZLC group (Figures 3G and 4B). In the Ex30-
ZDF group, COX-2 immunoreactivity in the hippocampal
CA3 region was significantly decreased compared to that in
the Ex30-ZLC group as well as in the Ex12-ZDF group. In
this group, COX-2 immunoreactivity was similar to that in
the Co30-ZLC group (Figures 3H and 4B).
Figure 2. Cyclooxygenase-2 (COX-2) immunoreactivity in the
dentate gyrus of Co12-ZLC (A), Co12-ZDF (B), Ex12-ZLC (C),
Ex12-ZDF (D), Co30-ZLC (E), Co30-ZDF (F), Ex30-ZLC (G)
and Ex30-ZDF (H) rats. COX-2 immunoreactivity is mainly
detected in the granule cell layer (GCL, asterisk) of the dentate
gyrus. Note that COX-2 immunoreactivity is strong in the
exercised group except in the Ex30-ZDF group. PL, polymorphic
layer; ML, molecular layer. Scale bar=100 µm.
Figure 3. COX-2 immunoreactivity in the hippocampal CA3
region of Co12-ZLC (A), Co12-ZDF (B), Ex12-ZLC (C), Ex12-
ZDF (D), Co30-ZLC (E), Co30-ZDF (F), Ex30-ZLC (G) and
Ex30-ZDF (H) rats. COX-2 immunoreactivity is observed in the
stratum pyramidal (SP, asterisk). Note that COX-2
immunoreactivity is strong in most exercised groups except the
Ex30-ZDF group. SO, stratum oriens; SR, stratum radiatum.
Scale bar=100 µm.Effect of diabetes on cyclooxygenase-2 193
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Discussion
COX-2 is a key enzyme in the conversion of arachidonic
acid to PGs and thromboxanes, and it is a target
 enzyme
for nonsteroidal anti-inflammatory drugs [1,19]. Recently,
COX-2 has been shown to participate in synaptic transmission
and plasticity through its downstream metabolite PGE2 [20-
24] and through both 2-arachidonoylglycerol and PGE2 [25].
In the present study, we observed the effects of diabetes
and/or exercise on COX-2 immunoreactivity in rats because
diabetes has been shown to impair synaptic plasticity and
learning and memory [8,26-28]. COX-2 immunoreactivity was
mainly detected in the hippocampal CA3 region and dentate
gyrus. The staining profiles in the rat brains were similar to
those in previous reports [1,29-31].
In the present study, COX-2 immunoreactivity was
prominently decreased in these regions in the early stage
of diabetes, but not in the chronic stage of diabetes. This
result is contradictory to a previous study that showed that
COX-2 was upregulated in the cerebral cortex of rats fed
a high-fat diet [32]. This difference may be associated with
different functions of COX-2 in the brain. COX-2 that is
expressed in the hippocampus is closely related to
neurogenesis in the brain. COX-2 was shown to participate
in the proliferation of neural progenitor cells following ischemic
insults [33,34]. COX-2 inhibitors significantly reduced cellular
proliferation and neuroblast differentiation in mice [35] and
rats [31] and suppressed increases in neurogenesis in the
hippocampus that followed acute global ischemia [36]. COX-
2-knockout mice exhibited impaired neurogenesis in the
hippocampus [34]. In addition, the administration of COX-
2 inhibitor significantly reduced microglia activation and
decreased hippocampal neurogenesis in epilepsy model [37].
This result is supported by our previous study that showed
that a reduction of neuroblast differentiation was more
pronounced at the early stage of diabetes than at the chronic
stage of diabetes [9]. However, COX-2 immunoreactivity was
increased in hippocampus of Alzheimer diseases [38,39]. This
discrepancy may be associated with the functions of COX-
2 in the hippocampus. Several studies demonstrated that COX-
2 immunoreactivity was significantly increased in the
hippocampus of neurological disorders such as stroke,
depression, epilepsy, schizophrenia, and amyotrophic lateral
sclerosis [40-46]. In these models, COX-2 may function as
the inflammatory mediators, while in the present study, COX-
2 is closely related to synaptic plasticity in the hippocampus.
In this study, COX-2 immunoreactivity was significantly
increased in the dentate gyrus and hippocampal CA3 region
in all groups. However, there were some differences between
control and diabetic animals. Control rats at 12 or 30 weeks
of age showed similar increases in the levels of COX-2
immunoreactivity due to treadmill exercise, while in the
diabetic rats, COX-2 immunoreactivity was only increased
at 12 weeks of age. At 30 weeks of age, COX-2 immuno-
reactivity was similar between sedentary and exercised groups.
This suggests that exercise in the chronic diabetic stage has
limited effects on COX-2 immunoreactivity. Exercise at an
early stage of diabetes did not increase blood glucose levels,
while exercise in the chronic stage of diabetes only decreased
the blood glucose levels.
In conclusion, treadmill exercise significantly increases COX-
2 immunoreactivity in the dentate gyrus and hippocampal
CA3 region in the early stages of diabetes but not in the
chronic stage of diabetes. These results suggest that treadmill
exercise enhances synaptic plasticity in the hippocampus in
the early stage of diabetes and not in the chronic stage of
diabetes.
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